Novel Therapeutic Targeting in Cancer: An Interdisciplinary Approach is the twenty-sixth volume of the acclaimed Interdisciplinary Cancer Research series. This comprehensive volume delves into groundbreaking therapeutic strategies in cancer treatment.
The book begins with an insightful chapter on the triad of telomere, DNA damage response, and nanomedicine as innovative approaches for cancer therapy. It then explores the realms of precision oncology and interdisciplinary pathways for enhanced cancer treatment outcomes.
Readers will discover advanced targeting systems focusing on tissue-specific drug delivery, alongside new-generation drug delivery systems serving as potent anticancer strategies. The volume also discusses the inhibition of cell proliferation in tumor microenvironments by targeting inflammatory proteins.
Key topics such as small RNAs, microRNAs, and the innovative use of CRISPR/Cas9 and microbiota genomics are thoroughly explained. The book further explores mechanisms like targeting glycans, lectin-based drug delivery systems, and proteolysis targeting chimeras.
Readers will gain insights into the roles of dihydrofolate reductase inhibitors, PARP, ATR, RUVBL1/2 complex, and metal-coordination complexes in cancer treatment. The final chapter offers a deep dive into computational advancements and in vitro evaluations in pre-clinical anticancer drug discovery and development.
Authors:
Nima Rezaei (Editor)
Publication Date:
January 1, 2026












Reviews
There are no reviews yet.